Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Income towards Parent Company: 2020-2025

Historic Income towards Parent Company for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $2.9 million.

  • Mirum Pharmaceuticals' Income towards Parent Company rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Income towards Parent Company stood at $2.9 million for Q3 2025, which was up 149.56% from -$5.9 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Income towards Parent Company ranged from a high of $57.3 million in Q4 2021 and a low of -$74.0 million during Q2 2023.
  • For the 3-year period, Mirum Pharmaceuticals' Income towards Parent Company averaged around -$24.5 million, with its median value being -$23.8 million (2024).
  • In the last 5 years, Mirum Pharmaceuticals' Income towards Parent Company soared by 253.52% in 2021 and then tumbled by 175.01% in 2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Income towards Parent Company (Quarterly) stood at $57.3 million in 2021, then plummeted by 163.60% to -$36.4 million in 2022, then climbed by 2.12% to -$35.7 million in 2023, then spiked by 33.28% to -$23.8 million in 2024, then spiked by 120.41% to $2.9 million in 2025.
  • Its Income towards Parent Company was $2.9 million in Q3 2025, compared to -$5.9 million in Q2 2025 and -$14.7 million in Q1 2025.